Quarterly report [Sections 13 or 15(d)]

Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details)

v3.25.2
Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock equivalents (in shares) 147,707 147,707 147,707 147,707
Non-vested restricted stock awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock equivalents (in shares) 192,907 826,315 192,907 826,315
Non-vested restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock equivalents (in shares) 1,915,211 2,777,715 1,915,211 2,777,715
Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock equivalents (in shares) 240,100 240,100 240,100 240,100
Convertible debt        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock equivalents (in shares) 1,176,471 583,333 1,176,471 583,333